Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,511 | 81 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $385.16 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $192.83 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $124.29 | 7 | $0 (2024) |
| Lilly USA, LLC | $106.98 | 6 | $0 (2024) |
| PFIZER INC. | $91.81 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $82.95 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $70.93 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66.42 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $48.55 | 3 | $0 (2024) |
| Amgen Inc. | $46.52 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $378.06 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($74.09) |
| 2023 | $322.13 | 17 | ABBVIE INC. ($93.54) |
| 2022 | $189.49 | 10 | ABBVIE INC. ($85.66) |
| 2021 | $248.61 | 14 | AbbVie Inc. ($114.56) |
| 2020 | $15.58 | 1 | PFIZER INC. ($15.58) |
| 2019 | $98.00 | 6 | Janssen Pharmaceuticals, Inc ($48.72) |
| 2018 | $208.87 | 11 | AbbVie, Inc. ($47.07) |
| 2017 | $50.01 | 3 | Abbott Laboratories ($20.60) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Obesity | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Genetic Disease | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Gastroenterology | ||||||
| 02/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 01/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Diabetes Care | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Gastroenterology | ||||||
| 11/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Obesity | ||||||
| 09/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,067 | 2,661 | $223,918 | $58,144 |
| 2022 | 16 | 1,061 | 1,401 | $190,492 | $38,939 |
| 2021 | 14 | 1,126 | 1,457 | $194,006 | $65,896 |
| 2020 | 14 | 1,166 | 1,505 | $202,567 | $57,203 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 1,326 | $33,000 | $23,970 | 72.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 330 | $57,750 | $13,819 | 23.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 176 | 176 | $35,200 | $7,925 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 199 | $49,750 | $5,405 | 10.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 71 | $2,130 | $2,087 | 98.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 101 | $30,150 | $1,365 | 4.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 133 | 141 | $10,575 | $1,212 | 11.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 61 | 94 | $2,350 | $894.88 | 38.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 36 | 36 | $900.00 | $680.40 | 75.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 36 | $1,080 | $414.36 | 38.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 86 | 86 | $1,032 | $368.94 | 35.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 65 | $0.65 | $0.65 | 100.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 197 | 407 | $71,225 | $16,772 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 167 | 167 | $33,400 | $7,041 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 195 | $48,750 | $3,871 | 7.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 28 | 30 | $3,750 | $1,991 | 53.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 64 | 65 | $1,950 | $1,912 | 98.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 12 | 12 | $2,085 | $1,693 | 81.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 125 | 132 | $9,900 | $1,228 | 12.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 75 | 121 | $3,025 | $1,161 | 38.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 13 | 14 | $1,050 | $711.16 | 67.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $4,200 | $582.96 | 13.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 42 | $1,260 | $489.02 | 38.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,100 | $463.68 | 42.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 24 | 24 | $600.00 | $457.19 | 76.2% |
About Dr. Felicia Meila, M.D
Dr. Felicia Meila, M.D is a Internal Medicine healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720049802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Felicia Meila, M.D has received a total of $1,511 in payments from pharmaceutical and medical device companies, with $378.06 received in 2024. These payments were reported across 81 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,511).
As a Medicare-enrolled provider, Meila has provided services to 4,420 Medicare beneficiaries, totaling 7,024 services with total Medicare billing of $220,182. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pawtucket, RI
- Active Since 03/29/2006
- Last Updated 11/14/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720049802
Products in Payments
- UBRELVY (Drug) $197.68
- FARXIGA (Drug) $134.95
- XIFAXAN (Drug) $124.29
- TRULICITY (Drug) $90.70
- ELIQUIS (Drug) $87.67
- QULIPTA (Drug) $83.50
- XARELTO (Drug) $82.95
- TRELEGY ELLIPTA (Drug) $54.02
- OFEV (Drug) $49.33
- YUPELRI (Drug) $48.55
- Wegovy (Drug) $42.18
- VRAYLAR (Drug) $40.41
- ONPATTRO (Drug) $35.54
- AIRSUPRA (Drug) $27.39
- CHANTIX (Drug) $26.46
- Synthroid (Drug) $23.72
- Prolia (Biological) $23.40
- Korlym (Drug) $23.38
- Androgel (Drug) $23.35
- Aimovig (Biological) $23.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pawtucket
Jeffrey Baron, Md, MD
Internal Medicine — Payments: $25,398
Omeed Sani, M.d, M.D
Internal Medicine — Payments: $16,518
Muhammad Ehtisham, M.d, M.D
Internal Medicine — Payments: $8,398
Rafael Liporaci Lucena, Md, MD
Internal Medicine — Payments: $6,813
Dr. Vinit Joseph Gilvaz, Md, MD
Internal Medicine — Payments: $3,785
Amber Gul, M.d, M.D
Internal Medicine — Payments: $3,620